Concepedia

Erik J. Flahive

EJ

Statistics

Publications

8

Citations

254

H-Index

8

Active since

1994

Affiliations

Pfizer (United States)(Current)

Arizona State University

Pfizer (United Kingdom)

Cancer Research Institute

Erik J. Flahive is an author at Pfizer (United States) specializing in medicinal chemistry, pharmacology, and synthetic medicinal chemistry.

Publications per year

1994–2015

8

Publications

8

Development of an Effective Palladium Removal Process for VEGF Oncology Candidate AG13736 and a Simple, Efficient Screening Technique for Scavenger Reagent Identification

Erik J. Flahive, Brigitte L. Ewanicki, Neal W. Sach et al. · Organic Process Research & Development · 2008 · 76 citations

, , +14

Design and Synthesis of Novel <i>N</i>-Hydroxy-Dihydronaphthyridinones as Potent and Orally Bioavailable HIV-1 Integrase Inhibitors

Ted W. Johnson, Steven P. Tanis, Scott L. Butler et al. · Journal of Medicinal Chemistry · 2011 · 43 citations · Full text

, , +14

The Dolastatins 20. A Convenient Synthetic Route to Dolastatin 15

George R. Pettit, Timothy J. Thornton, Jeffrey T. Mullaney et al. · Tetrahedron · 1994 · 28 citations

, , +5

Efficient Chemoenzymatic Synthesis of Pelitrexol via Enzymic Differentiation of a Remote Stereocenter

Shanghui Hu, Sean M. Kelly, Junhua Tao et al. · Organic Letters · 2006 · 26 citations

, , +17

Antineoplastic Agents. 599. Total Synthesis of Dolastatin 16

George R. Pettit, Thomas H. Smith, Pablo M. Arce et al. · Journal of Natural Products · 2015 · 23 citations

, , +13

1–5 of 8